InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Goldstein Joseph l, 董事. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 10 reports have been published. History available since 7 June 2021. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Goldstein Joseph l
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
155 股0Common StockSEC:0001225474-26-000002:0
166 股0Common StockSEC:0001968202-25-000004:0
2,707 股@ US$625.6023.0% 占其流量Common StockSEC:0001968202-24-000042:0
135 股0Common StockSEC:0001968202-24-000023:0
3,613 股@ US$482.6823.9% 占其流量Common StockSEC:0001883850-23-000046:0
165 股0Common StockSEC:0001883850-23-000018:0
2,431 股@ US$374.1215.2% 占其流量Common StockSEC:0001883850-22-000032:0
191 股0Common StockSEC:0001708138-22-000006:0
2,479 股@ US$380.9514.8% 占其流量Common StockSEC:0001708138-21-000076:0
1,930 股@ US$374.1211.0% 占其流量Common StockSEC:0001237899-21-000008:0
10 条申报中的 10 条
About Goldstein Joseph l
Joseph L. Goldstein serves as a Director at REGENERON PHARMACEUTICALS, INC. In this role, he contributes to the governance of the company and oversight of its operations. Goldstein plays a key role in developing the strategies and policies that guide the company in the pharmaceutical sector, ensuring that shareholder interests are protected.
